Artificial Intelligence
Artificial Intelligence
Computer modeling is an integral part of modern drug development.
Promomed Group employs a suite of advanced computational and medicinal chemistry methods that reduce the time and cost of developing new drug compounds, enabling efforts to be focused on the efficacy and safety of new medications.
Rational drug design using computational methods relies on a target-oriented approach; unlike "blind screening" techniques, modern molecules are engineered for a specific purpose, with every part of the chemical compound designed to perform a particular function.
Artificial intelligence and machine learning technologies
The use of artificial intelligence and machine learning technologies across all stages of research and development is a key area of focus.
AI is widely employed for information retrieval and analysis, as well as for predicting specific properties of objects. Modern generative AI models are used to generate virtual libraries of new molecules. As part of the implementation of AI technologies at Promomed Group, the company continuously enhances its internal *in silico* platform, which integrates a wide range of advanced software solutions.
Experimental studies
Despite the use of advanced technologies, a mandatory step involves confirming the potential of compounds selected through modeling by means of a comprehensive set of experimental studies. This implements the modern “in silico” – “in vitro” – “in vivo” approach.
Links to subsections
